[go: up one dir, main page]

TN2013000150A1 - Co-crystals and salts of ccr3-inhibitors - Google Patents

Co-crystals and salts of ccr3-inhibitors

Info

Publication number
TN2013000150A1
TN2013000150A1 TNP2013000150A TN2013000150A TN2013000150A1 TN 2013000150 A1 TN2013000150 A1 TN 2013000150A1 TN P2013000150 A TNP2013000150 A TN P2013000150A TN 2013000150 A TN2013000150 A TN 2013000150A TN 2013000150 A1 TN2013000150 A1 TN 2013000150A1
Authority
TN
Tunisia
Prior art keywords
ccr3
crystals
salts
inhibitors
same
Prior art date
Application number
TNP2013000150A
Other languages
French (fr)
Inventor
Markus Frank
Hans Haeberle
Manuel Henry
Thorsten Pachur
Marco Santagostino
Uwe Stertz
Thomas Trebing
Ulrike Werthmann
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/067437 external-priority patent/WO2012045803A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2013000150A1 publication Critical patent/TN2013000150A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to co-crystals and salts of CCR3 inhibitors of formula (1), pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases related with the CCR3-receptor.
TNP2013000150A 2011-10-06 2013-04-03 Co-crystals and salts of ccr3-inhibitors TN2013000150A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/067437 WO2012045803A1 (en) 2010-10-07 2011-10-06 Co-crystals and salts of ccr3-inhibitors

Publications (1)

Publication Number Publication Date
TN2013000150A1 true TN2013000150A1 (en) 2014-11-10

Family

ID=54360592

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000150A TN2013000150A1 (en) 2011-10-06 2013-04-03 Co-crystals and salts of ccr3-inhibitors

Country Status (1)

Country Link
TN (1) TN2013000150A1 (en)

Similar Documents

Publication Publication Date Title
PH12013500644A1 (en) Co-crystals and salts of ccr3-inhibitors
MD20150043A2 (en) Inhibitors of histone demethylases
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
TN2013000348A1 (en) Compounds and compositions as trk inhibitors
NZ708593A (en) Novel pyrazole derivative
IN2015DN01156A (en)
MY199894A (en) Prmt5 inhibitors and uses thereof
NZ700928A (en) Dna-pk inhibitors
IN2014CN04907A (en)
AU2012214029A8 (en) Rorgammat inhibitors
MY172924A (en) Neprilysin inhibitors
JO3115B1 (en) Pyridazinone Compounds and Their Use as DAAO Inhibitors
MX342924B (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases.
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
IN2015DN01151A (en)
SG195319A1 (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
MX2015008187A (en) Deuterated alk inhibitors.
MX2014004858A (en) Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies.
MX2012001134A (en) Compositions and methods for inhibition of the jak pathway.
IN2014MN01486A (en)
TN2013000150A1 (en) Co-crystals and salts of ccr3-inhibitors
MX2014002343A (en) Parp inhibitors.
TN2014000077A1 (en) Pyridazinone compounds and their use as daao inhibitors